Michele Ardolino

9PUBLICATIONS
51CO-AUTHORS
Molecular targetsHaematological tumoursInnate immunitySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 29, 2026
Preventing surgery-induced natural killer cell suppression and metastases by inhibiting PI3K-gamma signaling in myeloid-derived suppressor cells.

Leonard Angka, Gayashan Tennakoon, David P Cook

|Aug 05, 2025
CD8 T Cell Hyperfunction and Reduced Tumour Control in Murine Models of Advanced Liver Disease.

Jood Madani, Jiafeng Li, Ma Enrica Angela Ching

|Jul 24, 2025
LAG3 Marks Activated but Hyporesponsive NK Cells.

Valeria Vasilyeva, Olivia Makinson, Cynthia Chan

|Jun 13, 2024
PD-L1 promotes oncolytic virus infection via a metabolic shift that inhibits the type I IFN pathway.

Jonathan J Hodgins, John Abou-Hamad, Colin Edward O'Dwyer

|Jan 11, 2024
Sox10-Deficient Drug-Resistant Melanoma Cells Are Refractory to Oncolytic RNA Viruses.

John Abou-Hamad, Jonathan J Hodgins, Edward Yakubovich

Pageof 2